Kodiak Sciences (KOD) Accumulated Expenses (2017 - 2026)
Kodiak Sciences (KOD) reported Accumulated Expenses of $26.6 million for Q1 2026, up 98.5% on a YoY basis from $13.4 million in Q1 2025, and up 28.93% quarter-over-quarter from $20.6 million in Q4 2025.
Kodiak Sciences (KOD) Accumulated Expenses (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Accumulated Expenses for 10 years, with the latest figure at $26.6 million in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Expenses rose 98.5% year-over-year to $26.6 million; the trailing twelve-month figure through Mar 2026 stood at $26.6 million (up 98.5% YoY), and the FY2025 full-year result was $20.6 million, up 291.32% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $26.6 million, up from $20.6 million in the prior quarter.
- The five-year high for Accumulated Expenses was $33.4 million in Q4 2022, with the low at $2.6 million in Q3 2024.
- Historically, Accumulated Expenses has averaged $11.1 million across 5 years, with a median of $7.3 million in 2022.
- Annual changes were most pronounced in 2022 — Accumulated Expenses tumbled 86.59% — and 2025, when it surged 673.23%.
- Kodiak Sciences' Accumulated Expenses stood at $33.4 million in 2022, then slumped by 74.1% to $8.7 million in 2023, then plunged by 39.21% to $5.3 million in 2024, then soared by 291.32% to $20.6 million in 2025, then rose by 28.93% to $26.6 million in 2026.
- The last three Accumulated Expenses figures came in at $26.6 million (Q1 2026), $20.6 million (Q4 2025), and $20.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.57 Mn |
| Dec 31, 2025 | 20.61 Mn |
| Sep 30, 2025 | 20.31 Mn |
| Jun 30, 2025 | 5.02 Mn |
| Mar 31, 2025 | 13.39 Mn |
| Dec 31, 2024 | 5.27 Mn |
| Sep 30, 2024 | 2.63 Mn |
| Jun 30, 2024 | 9.44 Mn |
| Mar 31, 2024 | 5.68 Mn |
| Dec 31, 2023 | 8.66 Mn |
| Sep 30, 2023 | 5.41 Mn |
| Jun 30, 2023 | 3.53 Mn |
| Mar 31, 2023 | 4.12 Mn |
| Dec 31, 2022 | 33.44 Mn |
| Sep 30, 2022 | 5.23 Mn |
| Jun 30, 2022 | 12.19 Mn |
| Mar 31, 2022 | 7.33 Mn |
| Dec 31, 2021 | 6.04 Mn |
| Sep 30, 2021 | 39.02 Mn |
| Jun 30, 2021 | 37.03 Mn |